Aims and Scope

Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.


Impact factor

2016 Impact Factor 4.730*

Rank:22/142 in Psychiatry

*2016 Journal Citation Reports® Science Edition (Clarivate Analytics, 2017)


Abstracted/indexed in

PubMed Central
ISI Web of Science
British Library



The ISSN (online) number for Translational Psychiatry is 2158-3188.




Julio Licinio, MD

Julio Licinio, M.D., FRANZCP, is Deputy Director for Translational Medicine and Head, Mind and Brain Theme at the South Australian Health and Medical Research Institute and Strategic Professor of Psychiatry, Flinders University in Adelaide, South Australia. He is also a Research Professor at the University of Southern California, in Los Angeles. He was previously Professor and Director, John Curtin School of Medical Research, The Australian National University (ANU), and head of the Department of Translational Medicine (2009-2013). Professor Licinio is originally from Brazil and lived for over 25 years in the United States, where he had clinical and research training in endocrinology and psychiatry at University of Chicago, Albert Einstein College of Medicine and Cornell. Professor Licinio is recognised internationally as a leader in translational research in depression and obesity. He has conducted depression research for over 20 years at Yale, NIH, UCLA, University of Miami and at the ANU, with key leadership positions in those institutions. He is also the current and founding Editor of three Nature Publishing Group journals: Molecular Psychiatry (Impact Factor: 14.897, #1-ranked in Psychiatry), The Pharmacogenomics Journal (Impact Factor 5.134) and Translational Psychiatry. Professor Licinio's translational and genomics research spans the lab and clinic examining obesity, depression, and their interface.

Editorial Board Members

M Bauer, Technische Universität Dresden, Germany
B T Baune, University of Adelaide, Australia
M Berk, Deakin University, Australia
W H Berrettini, University of Pennsylvania, USA
P Brown, Australia
J Buxbaum, Mount Sinai Hospital, USA
H Christensen, The Black Dog Institute, Australia
G Chrousos, University of Athens, Greece
D A Collier, King's College London, UK
J T Coyle, McLean Hospital, USA
K L Davis, Mount Sinai Health System, USA
I P Everall, University of Melbourne, Australia
D Geschwind, University of California Los Angeles, USA
P Greengard, The Rockefeller University, USA
J A Gustafsson, Sweden
P Harrison, Oxford University, UK
S Henderson, The Australian National University, Australia
I Hickie, The University of Sydney, Australia
S E Hyman, USA
A Jablensky, Australia
D V Jeste, University of California San Diego, USA
M Kato, Japan
K Kendler, Virginia Commonwealth University, USA
J Kleinman, Lieber Institute for Brain Development, USA
S Koslow, University of Miami, USA
R Krishnan, Dean Rush University, Singapore
B Lerer, Hebrew University Medical Center, Israel
P Magistretti, Université de Lausanne, Switzerland
G Malhi, University of Sydney, Australia
N Martin, Queensland Institute of Medical Research, Australia
C L Masters, University of Melbourne, Australia
B S McEwen, The Rockefeller University, USA
J J McGrath, University of Queensland, Australia
P McGuffin, Kings College London, UK
M J Morris, Australia
A B Niculescu, Indiana University School of Medicine, USA
M Owen, Cardiff University, UK
C Pariante, King's College London, UK
C Pato, USA
R Plomin, King's College London, UK
D Porteous, Western General Hospital, UK
B Raphael, Australia
A Schally, Veteran Affairs Administration, USA
A Schatzberg, Stanford University, USA
M Schwartz, Weizmann Institute of Science, Israel
A Serretti, University of Bologna, Italy
C Shannon Weickert, University of New South Wales, Australia
S Snyder, Johns Hopkins University, USA
J Soares, The University of Texas at Austin, USA
M Valenzuela, University of New South Wales, Australia

Extra navigation

Sign up for e-alerts Web feed Top ten